Cargando…

Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma

This unusual case of concurrent eccrine adenocarcinoma, phyllodes tumor, and multinodular goiter serves to alert the oncologic community to the high prevalence of second cancers after childhood radiotherapy. Increased surveillance and index of suspicion are recommended to successfully diagnose and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Kristen M., Tozbikian, Gary, Carson, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293260/
https://www.ncbi.nlm.nih.gov/pubmed/30564357
http://dx.doi.org/10.1002/ccr3.1854
_version_ 1783380511610109952
author Quinn, Kristen M.
Tozbikian, Gary
Carson, William E.
author_facet Quinn, Kristen M.
Tozbikian, Gary
Carson, William E.
author_sort Quinn, Kristen M.
collection PubMed
description This unusual case of concurrent eccrine adenocarcinoma, phyllodes tumor, and multinodular goiter serves to alert the oncologic community to the high prevalence of second cancers after childhood radiotherapy. Increased surveillance and index of suspicion are recommended to successfully diagnose and treat second primary cancers in this vulnerable population.
format Online
Article
Text
id pubmed-6293260
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62932602018-12-18 Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma Quinn, Kristen M. Tozbikian, Gary Carson, William E. Clin Case Rep Case Reports This unusual case of concurrent eccrine adenocarcinoma, phyllodes tumor, and multinodular goiter serves to alert the oncologic community to the high prevalence of second cancers after childhood radiotherapy. Increased surveillance and index of suspicion are recommended to successfully diagnose and treat second primary cancers in this vulnerable population. John Wiley and Sons Inc. 2018-11-06 /pmc/articles/PMC6293260/ /pubmed/30564357 http://dx.doi.org/10.1002/ccr3.1854 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Quinn, Kristen M.
Tozbikian, Gary
Carson, William E.
Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title_full Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title_fullStr Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title_full_unstemmed Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title_short Concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for Hodgkin lymphoma
title_sort concurrent phyllodes tumor, eccrine carcinoma, and multinodular goiter 20 years after radiotherapy for hodgkin lymphoma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293260/
https://www.ncbi.nlm.nih.gov/pubmed/30564357
http://dx.doi.org/10.1002/ccr3.1854
work_keys_str_mv AT quinnkristenm concurrentphyllodestumoreccrinecarcinomaandmultinodulargoiter20yearsafterradiotherapyforhodgkinlymphoma
AT tozbikiangary concurrentphyllodestumoreccrinecarcinomaandmultinodulargoiter20yearsafterradiotherapyforhodgkinlymphoma
AT carsonwilliame concurrentphyllodestumoreccrinecarcinomaandmultinodulargoiter20yearsafterradiotherapyforhodgkinlymphoma